Baltimore VA Medical Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Multiple sclerosis1 trial
• Obesity1 trial
• Prostate cancer1 trial
• Type 1 diabetes1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Accelerated Cure Project for Multiple Sclerosis1 trial
• Baltimore VA Medical Center1 trial
• Hoffmann-La Roche1 trial
• Janssen Research & Development, LLC1 trial
• Tandem Diabetes Care, Inc.1 trial
• and 1 more

Running trials

• Recruiting

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· Phase 3· Hoffmann-La Roche· Source

• Enrolling by invitation

  Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

  NCT06441617· Accelerated Cure Project for Multiple Sclerosis· Source

• Recruiting

  A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

  NCT05762107· Phase 2· Zucara Therapeutics Inc.· Source

  Contact: William Scott

• Active, not recruiting

  A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

  NCT04497844· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes

  NCT01176578· Baltimore VA Medical Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis1 recruiting
• Obesity1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Tandem Diabetes Care, Inc.· Source